Wang Huiqing, Chairman of Jiangsu Gaotou Group, inspects the work of Wuxi Zhanxin Fund

　　On February 14th, Wang Huiqing, Secretary of the Party Committee and Chairman of Jiangsu High tech Investment Group, visited Wuxi to investigate the operation of the Strategic Emerging Industries Mother Fund. Gu Wei, Deputy Secretary of the Party Committee and President of Guolian Group, and Hua Xiaofeng, Vice President of Guolian Group and Chairman of Xichuang Capital, participated in the research.

　　Wang Huiqing and his delegation visited three representative enterprises in the biopharmaceutical and integrated circuit industries in Wuxi, namely Wuxi Zhikang Hongyi Biotechnology Co., Ltd., Wuxi Xinxiang Information Technology Co., Ltd., and Jimxi Semiconductor Technology (Wuxi) Co., Ltd. They listened to their introductions on production and operation, technological innovation, product research and development, held discussions and exchanges with relevant personnel, and went deep into the enterprise laboratory and production workshop to gain a comprehensive understanding of the enterprise's research and development capabilities and production situation.

　　Wang Huiqing pointed out that since its launch, the Jiangsu Province Zhanxin Mother Fund has promoted the landing of two batches of 36 funds with a total scale of 91.4 billion yuan through a three-tier structure of "provincial mother fund industry special fund industry sub fund", covering 12 prefecture level cities and 4 provincial enterprises. Among them, Wuxi has established a special mother fund for integrated circuits and biomedicine with a total scale of 9 billion yuan, as well as a future industry angel fund with a scale of 1 billion yuan. It is also setting up a special mother fund for low altitude economy and aerospace industry with a scale of 2 billion yuan, which has become an important pivot for the province's industrial layout.

　　Wang Huiqing emphasized that the Zhanxin Mother Fund should fully leverage its "leverage" effect, focus on advantageous industries, strengthen strategic layout, and focus on supporting the high-quality development of the two strategic emerging industries of integrated circuits and biomedicine in Wuxi and the whole province, accelerating the agglomeration of the industrial chain; We must firmly position ourselves as patient capital, adhere to the principles of "investing early, investing small, investing long-term, and investing in hard technology", assist in the transformation of scientific research achievements and industrial incubation, and provide stable support for technological innovation; We should focus on solving the bottleneck problem, actively serve the national strategic needs, strive to break through the bottleneck constraints in industrial development, and further strengthen the independent and controllable capabilities in key areas.

　　This survey further clarified the strategic positioning and implementation path of Wuxi Zhanxin Fund. In the future, through the continuous investment of "patient capital", it will achieve precise layout and full chain innovation, and contribute to the important position of industrial and technological innovation and accelerated development of new quality productivity in the province.

　　　　　　　　　　　　　　　　　Background link

　　Since its launch in June 2024, the Jiangsu Province Zhanxin Mother Fund has completed two batches of fund contracts in just 8 months, with a total scale of 91.4 billion yuan, building a fund network covering the whole province. As an important node, Wuxi is accelerating the construction of two billion dollar industrial clusters, integrated circuits and biomedicine, through the "fund+industry" model, injecting strong momentum into the high-quality development of strategic emerging industries in the province.

　　　　　　　　　　　　　　　　　　Zhikang Hongyi

　　Zhikang Hongyi is a biotechnology company dedicated to the research and development of innovative drugs in the fields of cancer and kidney disease, committed to developing "Best in Class" and "First in Class" new drugs with global leading potential.

　　　　　　　　　　　　　　　　　Xinxiang Technology

　　Xinxiang Technology is a leading semiconductor factory production automation CIM (Computer Integrated Manufacturing) solution service provider in China, focusing on providing intelligent automation software and hardware systems with independent intellectual property rights and one-stop IT services for wafer manufacturing and packaging testing fields.

　　　　　　　　　　　　　　　　　Jimsy Semiconductor

　　Jimxi Semiconductor Technology (Wuxi) Co., Ltd. is a leading semiconductor equipment supplier in China, specializing in the research and development, manufacturing, sales, and service of semiconductor process equipment, process auxiliary equipment, and CMP consumables.